CpG site methylation of HCV-cirrhotic, HCV-HCC, and normal liver tissues. Homo sapiens

In this study we used a high-throughput method for assaying methylation of CpG sites simultaneously in a single sample for identifying differences in methylation observed in tissues ranging from normal liver to pre-neoplastic (cirrhosis) and neoplastic (HCC) states. Since there are important clinical and prognostic differences among HCC patients due to etiology, this study was designed to focus on HCC due to HCV-infection, a more common etiology of HCC among Western countries Overall design: cross-sectional: 20 cirrhosis, 20 HCC, and 16 normal patients, 87 arrays